Interactive Session - Is Oocyte Cryopreservation Preferable to Ovarian Tissue Freezing for Fertility Preservation? Debate

Date:October 22, 2014

Time:1:15 pm - 2:15 pm

Location:HCC316 - Hawaii Convention Center

Presenters

Samantha M. Pfeifer, M.D. (Chair), Weill Cornell Medical College

Nicole L. Noyes, M.D., New York University School of Medicine

Kutluk Oktay, M.D., New York Medical College

Supporters

Supported by an educational grant from Ferring Pharmaceuticals, Inc.

(Debate)

Needs Assessment and Description
Oocyte cryopreservation is increasingly recognized as an established technique and advocated to preserve fertility in women who are undergoing gonadotoxic therapy as an option for those who choose to electively preserve their fertility. Ovarian tissue cryopreservation is a technique still considered experimental that has been advocated as an alternative to oocyte cryopreservation for similar indications. The aim of this interactive session is to debate the advantages and disadvantages of each of these procedures and to determine which technique is preferred for each indication. The target audience is physicians, laboratory scientists, and allied health-care professionals with an interest in fertility preservation. 

Learning Objectives
At the conclusion of this session, participants should be able to: 

  1. Discuss the risks, benefits, and success of oocyte cryopreservation and ovarian tissue cryopreservation. 
  2. Evaluate the merits of each procedure for fertility preservation. 
ACGME Competency
Patient Care 

TEST QUESTION
After this session, I will do the following in my practice:
a. Recommend elective oocyte cryopreservation to all single women of reproductive age.
b. Recommend elective ovarian tissue cryopreservation to all single women of reproductive age.
c. Promote oocyte cryopreservation rather than ovarian tissue cryopreservation for women of reproductive age facing gonadotoxic therapy.
d. Promote oocyte cryopreservation rather than ovarian tissue cryopreservation for prepubertal females facing gonadotoxic therapy.
e. Not recommend oocyte cryopreservation or ovarian tissue cryopreservation.
f. Not applicable to my area of practice

ASRM MEMBERSHIP

View Details
Learn More | Join | Renew
Back to Top